An interventional study of Exercise training in Heart Failure With Preserved Ejection Fraction, sponsored by Meir Medical Center. Status unknown at 1 site in Israel. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2012-03-19.
Sponsored by Meir Medical Center · Not applicable, Interventional, and Treatment
The purpose of this study is to determine whether exercise training will improve functional capacity in patients with heart failure and preserved ejection fraction.
5,701 studies on the registry are indexed under Heart Failure; 1,219 are open to participants now.
This study's planned enrollment of 80 is above the median of 72 across 3,733 interventional studies indexed under Heart Failure.
Browse Heart Failure studies →Meir Medical Center is the lead sponsor of 389 studies on the registry; 34 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Protocol of 3 month exercise training program.
Behavioral: Exercise training
Control group
Exercise training program for 3 months (two times a week).
Change from baseline of peak oxygen uptake on graded exercise.
Changes in physical fitness after 3 month exercise training. This will be measured by a cardiopulmonary exercise test with recording of maximal oxygen uptake during incremental exercise.
Time frame: After 3 month exercise training
Change from baseline of six minute walk
Change in the distance covered during a 6 minute walk after 3 month exercise training.
Time frame: After 3 month exercise training
Change from baseline of NYHA class
Change in subjective assessment of function capacity based on the New York Heart Association Class classification after 3 month exercise training.
Time frame: After 3 month exercise training
This study is status unknown, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Meir Medical Center